First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.
Cicconi P. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70, 2073 - 2081
Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
Atcheson E. et al, (2020), Hepatology (Baltimore, Md.), 71, 794 - 807
Divergent memory responses driven by adenoviral vectors are impacted by epitope competition.
Colston JM. et al, (2019), European journal of immunology, 49, 1356 - 1363
Single-cell transcriptome analysis of CD8+ T-cell memory inflation
Highton AJ. et al, (2019), Wellcome Open Research, 4, 78 - 78
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
Green CA. et al, (2019), The Journal of infection, 78, 382 - 392
Memory inflation following adenoviral vaccination depends on IL-21
Gordon CL. et al, (2018), Vaccine, 36, 7011 - 7016
Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8+ T Cells by Persistent Viruses and Vaccines
Gordon CL. et al, (2018), Cell Reports, 23, 768 - 782
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
von Delft A. et al, (2018), Vaccine, 36, 313 - 321
Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order
Lee LN. et al, (2017), PLOS Pathogens, 13, e1006782 - e1006782
Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis
Arnold IC. et al, (2015), Vaccine, 33, 1808 - 1814
Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis
Arnold IC. et al, (2015), Vaccine, 33, 1808 - 1814
A Novel Murine Cytomegalovirus Vaccine Vector Protects against Mycobacterium tuberculosis
Beverley PCL. et al, (2014), The Journal of Immunology, 193, 2306 - 2316
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
O’Hara GA. et al, (2012), The Journal of Infectious Diseases, 205, 772 - 781
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
Porter DW. et al, (2011), Vaccine, 29, 7514 - 7522
Correction: Multiple functions of human T cells generated by experimental malaria challenge
Todryk SM. et al, (2011), European Journal of Immunology, 41, 1176 - 1176
Multiple functions of human T cells generated by experimental malaria challenge
Todryk SM. et al, (2009), European Journal of Immunology, 39, 3042 - 3051
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria
Schmidt NW. et al, (2008), Proceedings of the National Academy of Sciences, 105, 14017 - 14022
Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
Thompson FM. et al, (2008), PLoS ONE, 3, e1493 - e1493
Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge
Hutchings CL. et al, (2007), Infection and Immunity, 75, 5819 - 5826
New insights into the altered adhesive and mechanical properties of red blood cells parasitized by Babesia bovis
Hutchings CL. et al, (2007), Molecular Microbiology, 65, 1092 - 1105